WebJun 20, 2024 · Patienten und Methoden: In der placebokontrollierten Ausgangsstudie focuSSced wurden insgesamt 212 Patienten über 48 Monate mit Tocilizumab oder Placebo behandelt, in der offenen Anschlussstudie erhielten 167 Patienten über den Zeitraum 48 bis 96 Monate eine wöchentliche subkutane Injektion von 162 mg Tocilizumab. In die … WebAug 28, 2024 · focuSSced was a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial done at 75 sites in 20 countries across Europe, North America, Latin America, and Japan (eg, clinics, research office, and hospital settings). The study was done in accordance with the principles of the Declaration of Helsinki and Good Clinical Practice ...
FDA Approves First Biologic for SSc-ILD – PharmaLive
WebA Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc) [focuSSced] Official Title: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis : Secondary IDs: WebMar 5, 2024 · The focuSSced (NCT02453256) study was a Phase III, multicentre, randomised, double-blind, placebo-controlled, parallel-group trial to assess the efficacy … faiz shakir more perfect union
アクテムラ、成人の全身性強皮症に伴う間質性肺疾 …
WebNov 27, 2024 · The focuSSced study of tocilizumab. For example, in the phase 3 focuSSced study comparing the interleukin-6 (IL-6) receptor–alpha antibody tocilizumab (Actemra) with placebo in patients with SSc, the primary endpoint of mean change from baseline in mRSS was not met (–6.14 vs. –4.41 points with tocilizumab vs. placebo, … WebMar 18, 2024 · Dear Editor, In the Phase II faSScinate [] and Phase III focuSSced [] clinical trials, tocilizumab, an anti-IL-6 receptor antibody, demonstrated consistent and clinically meaningful benefit on lung function decline in dcSSc assessed by change in forced vital capacity (FVC), a validated measure of SSc-associated interstitial lung disease (SSc … faiz shakir twitter